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Abstract. 
Null mutations in Artemis confer a condition described as RS-SCID, in which patients 
display radiosensitivity combined with severe combined immunodeficiency. Here, we 
characterise the defect in Artemis in a patient who displayed progressive combined 
immunodeficiency and elevated lymphocyte apoptosis. The patient is a compound 
heterozygote with novel mutations in both alleles, resulting in Artemis proteins with 
either L70 deletion or G126D substitution. Both mutational changes impact upon Artemis 
function and a fibroblast cell line derived from the patient (F96-224) has reduced 
although detectable Artemis protein. In contrast to Artemis null cell lines, which fail to 
repair a subset of DNA double strand breaks (DSBs) induced by ionising radiation, F96-
224 cells show slow but residual DSB rejoining. F96-224 cells are proficient in V(D)J 
recombination using a plasmid assay. Despite these intermediate cellular and clinical 
features, F96-224 cells are as radiosensitive as Artemis null cell lines.  We developed a 
FACS based assay to examine  cell division and cellular characteristics  for10 days 
following exposure to ionising radiation (2 and 4 Gy). This analysis demonstrated that 
F96-224 cells show delayed cell death compared to rapid growth arrest of an Artemis null 
cell line, and the emergence of a cycling population shown by a control line, representing 
a novel phenotype of a hypomorphic cell line.  F96-224 cells also display elevated 
chromosome aberrations and dicentrics compared to control cells. We relate our findings 
to the novel progressive combined immunodeficiency phenotype of the Artemis patient.  
 
 
Introduction. 
DNA damage poses a major threat to multicellular organisms since it can lead to genomic 
instability and cancer.  DNA double-strand breaks (DSBs) are particularly significant and 
potentially lethal lesions that result from damage by exogenous agents such as ionizing 
irradiation and potentially by reactive oxygen species (ROS) generated as  by-products of 
cellular metabolism. DSBs also occur during  programmed DNA rearrangement in V(D)J 
recombination, a process by  which immunoglobulin and T-cell receptor genes are 
assembled in the  mammalian immune system to generate B and T cell antigen 
specificity.  
DNA non-homologous end joining (NHEJ)  pathway is the predominant 
mechanism for repairing DSBs in mammalian cells (1). The  core NHEJ apparatus 
includes the DNA-dependent protein kinase (DNA-PK) which is composed of the 
heterodimeric Ku protein (Ku70 and  Ku80) and its catalytic subunit, DNA-PKcs and a 
ligation complex which encompasses DNA  ligase IV and XRCC4. However, ends 
generated by DNA damage are rarely directly ligatable and recent studies have identified 
Artemis as a nuclease involved in processing DNA ends prior to ligation by NHEJ (2, 3). 
Artemis is required to repair approximately 10 % of the DSBs induced by γ-irradiation, 
which represent those rejoined with slow kinetics in mammalian cells. It has been argued 
that these represent ends that require processing prior to rejoining (4). Additionally, 
Artemis is required to cleave the hairpin end generated during V(D)J recombination (5).  
Artemis nuclease activity requires DNA-PKcs consolidating its role in NHEJ {Ma, 2002 
#9742.  
Patients with mutations in Artemis have been identified and designated RS-SCID 
(radiosensitive severe combined immunodeficiency) due to their associated 
radiosensitivity and immunodeficiency, both representing outcomes of the characterised 
roles of Artemis in end-processing {Moshous, 2001 #9321}. The majority of Artemis 
patients display marked T-B- severe combined immunodeficiency (SCID) and have 
genomic deletions causing loss of protein function (null mutations) (3, 6). Patients 
displaying combined immunodeficiency (CID) with point mutational changes in Artemis 
have also been reported (7). Since these patients displayed CID rather than the SCID 
observed in patients with genomic deletions, the mutations identified were considered to 
be hypomorphic. Interestingly, two of the patients developed EBV lymphoma. One 
patient displaying Omenn’s syndrome, another ‘leaky’ form of T-B-SCID with 
immunodeficiency, erythroderma, lymphadenopathy, and hepatosplenomegaly, has also 
been shown to have Artemis mutations, which again were considered to be 
hypomorphic(8). 
We previously described a patient with progressive CID characterized by 
lymphopenia, whose lymphocytes showed elevated apoptosis and whose fibroblasts 
displayed radiosensitivity(9). We were unable to detect cell cycle checkpoint defects, 
V(D)J recombination defects, or impaired DSB repair in a fibroblast  line (F96-224) 
derived from the patient. Using more sophisticated assays for detecting DSB repair than 
were available at the time of our initial analysis, we re-examined F96-224 cells and 
identified a subtle DSB repair defect consistent with impaired but not ablated Artemis 
function. We, therefore, report a sensitive procedure capable of detecting impaired but 
residual Artemis function. Sequencing verified the patient to be an Artemis compound 
heterozygote. Surprisingly, although the DSB repair kinetics and V(D)J recombination 
defect are distinct to cells with null Artemis mutations, the level of radiosensitivity is 
indistinguishable between F96-224 and an Artemis null cell line. Examination of cell 
cycle progression post irradiation demonstrated that whereas Artemis null cells fail to 
recover from G2/M arrrest after exposure to 2 or 4 Gy and control cells continue 
progression, a significant population of F96-224 cells progress through 6-7 divisions 
before arresting as small cells. Our findings, therefore, provide evidence for delayed cell 
death in this cell line, which we relate to the progressive CID observed in the patient. We 
consider our findings in terms of a breakage bridge fusion model.  
 Results. 
F96-224 is DSBR deficient due to compound heterozygous mutations in Artemis 
We previously used pulsed field gel electrophoresis (PFGE) to examine DSB repair in 
F96-224 cells and reported a normal rate of repair following exposure to 30 Gy (9). Our 
recent studies have demonstrated that analysis of the rate of loss of γ-H2AX foci post 
irradiation represents a markedly more sensitive DSB repair assay (2). Analysis of F96-
224 cells following exposure to 3 Gy γ-rays, revealed a subtle but reproducible DSB 
repair defect detectable at 24 and 48 h post IR (Fig. 1A). However, DSBs were repaired 
slowly such that by 4-6 days post irradiation no elevated unrepaired DSBs were 
detectable (Fig. 1A). This defect is distinct to that displayed by F92/385, an Artemis null 
cell, where approximately 10 % of the DSBs remain unrepaired for long times post 
irradiation. It is notable, however, that both lines show normal DSB repair kinetics at 
early times post treatment (up to 6 h), which contrasts to the defect observed in a cell line 
derived from a LIG4 syndrome patient (180BR). These findings demonstrate that, in 
contrast to our previous conclusion, F96-224 cells show a subtle DSB repair defect and 
that γ-H2AX foci analysis represents a valuable assay to detect DSB repair defects in 
patients. 
The DSB repair profile of F96-224 cells raised the possibility that the cells might 
have a mutation in a component required for Artemis-ATM dependent DSB repair. 
Candidate defects include Artemis and components of the MRN complex. Our previous 
studies demonstrated that F96-224 cells are proficient for radiation induced G1/S, intra-S 
and G2/M checkpoint arrest (9). NBS and ATLD deficient cells display intra-S phase 
checkpoint defects suggesting that this aspect of the MRN complex is functional in F96-
224 cells. Sequencing, moreover, revealed a normal Nbs1 sequence. In contrast, 
sequencing of Artemis revealed a three base pair deletion (∆GTT207-9) in exon 3 in one 
allele and a base substitution 377G>A in exon 6 on the other allele, which result in loss 
of a single amino acid (L70) and an amino acid substitution (G126D), respectively (data 
not shown). Examination of Artemis expression in F96-224 cells by western blotting 
revealed markedly reduced levels of Artemis protein but, in distinction to Artemis null 
cells, a low level of residual protein is detectable (Fig. 1B). To verify that the mutations 
observed in F96-224 represent impacting mutational changes rather than polymorphisms, 
we introduced ∆GTT207-9 and 377G>A into myc-tagged Artemis cDNA by site-directed 
mutagenesis and examined the ability of the mutant cDNAs to complement the DSB 
repair defect in CJ179 nTERT (Artemis null) cells using 53BP1 foci analysis as a monitor 
of DSB repair. We have previously shown that γ-H2AX and 53BP1 foci not only co-
localise but are present in equal numbers and are lost with identical kinetics (data not 
shown). 53BP1 foci were examined rather than γ-H2AX because phospho-53BP1 and 
myc antibodies require distinct secondary antibodies and can be used in conjunction. 
Since, most human cell lines including CJ179 hTERT cells undergo inefficient 
transfection, we monitored DSB repair solely in those cells expressing Myc.   The wild 
type Artemis cDNA substantially corrected the DSB repair defect in CJ179 hTERT cells 
whereas ∆GTT207-9  and 377G>A Artemis cDNAs failed to provide any substantial 
level of correction (Fig. 1C). The lack of full correction by the wild type cDNA likely 
represents the fact that Artemis may not be efficiently expressed. Taken together these 
results provide strong evidence that F96-224 cells have impacting mutational changes in 
Artemis that underlie their DSB repair deficiency.  
 
F96-224 cells display delayed cell death after irradiation. 
Our previous analysis of V(D)J recombination in F96-224 cells using a plasmid assay 
demonstrated nearly normal V(D)J recombination proficiency (9). Despite this and the 
fact that DSBs were repaired to normal levels, albeit with slow kinetics, we previously 
observed significant radiosensitivity in F96-224 cells. Here, we show that the magnitude 
of radiosensitivity of F96-224 cells is similar to that shown by an Artemis null cell line 
(Fig. 2). To gain insight into the mechanism of cell death in F96-224 cells, we devised a 
procedure (the CFSE assay) to couple the analysis of cell division with cell 
characteristics (granularity and cell size). Our aim was to identify the time and cell state 
at which control, F96-224 and Artemis null cells cease division after exposure to 
irradiation. CFSE  (Carboxy-fluorescein diacetate succinimidyl ester) is a fluorescent dye 
that is stably maintained in the cytoplasm of cells. Following each cell division the 
intensity of fluorescence halves. Thus, the intensity of fluorescence signal (represented 
by the position on the X-axis) provides a monitor of cell division. Using FACS analysis 
to monitor the intensity of CFSE, we were able to estimate the number of divisions  a cell 
has passed through since labeling (Fig. 3A). Immediately after labelling, control cells 
have a high CFSE content (Fig. 3A). Following 6 days incubation without irradiation, the 
CFSE content is reduced to a level indicative of the number of cell divisions (Fig. 3A). 
Irradiated cells  analysed at 6 days post treatment show a profile indicating a mixed 
population of arrested and dividing cells. We also used forward and side scatter FACS 
analysis to separate cells based on cell size and granularity. Cell size provides an 
indicator of cell cycle state, with G1 cells being small, cells in late G2 being larger and 
more granular, and senescent cells being generally very large and granular (Fig. 3B). For 
analysis of CFSE, we divided the cells into two populations: those with normal cell size 
and granularity (low forward and side scatter depicted by the left hand panels in Fig. 3B) 
and larger, granular cells (high forward and side scatter; right hand panel in Fig. 3B). The 
CFSE content was monitored by FACs following gating for each population to determine 
whether the cells with low or high CFSE content represent actively dividing or arrested 
cells. 
Initially, this assay was applied to control, F96-224 and CJ179 cells that were 
pulse labelled with CFSE prior to irradiation.. Following removal of the dye, cells were 
irradiated with 2 or 4 Gy IR, then analysed by FACS for CFSE content at 6 days post 
treatment. Irradiated control cells show significant early recovery from both doses of IR. 
Six days after irradiation 70% (2 Gy) and 31% (4 Gy) of 1BR3 cells had completed 5 
divisions (Fig. 4A). Irradiated Artemis null cells, in contrast, show highly reduced cell 
division (high CFSE levels), with only 16% (2 Gy) and 8% (4 Gy) completing 5 cycles. 
Surprisingly, F96-224 cells showed significant levels of cells passing through 5 divisions 
during this early post irradiation period, (49% at 2 Gy and 20% (at 4 Gy) (Fig. 4B). When 
the cells were plotted according to CFSE content and cell size it was clear that IR induced 
all but a small proportion of Artemis null CJ179 cells to arrest as large cells after no more 
than one division (Fig. 4B). In contrast, a significant proportion of F96-224 cells were 
present as small dividing cells, resembling recovering wild type cells. This was 
unexpected given that F96-224 and CJ179 show similarly low survival following 
exposure to 4 Gy. We, therefore, extended the analysis to identify the point at which F96-
224 cells cease to divide.  
CFSE fluorescence diminishes to undetectable levels after 6 or 7 divisions. To 
determine the fate of F96-224 cells dividing beyond 6 days after IR, irradiated cells (4 
Gy) were incubated for 6 days, then labelled  with CFSE. While the majority of control 
cells continue to cycle, and Artemis null cells remain arrested, the F96-224 cells still 
dividing after 6 days progress through a further 1-2 cell divisions and then arrest as small 
cells (Fig. 5A). A much smaller proportion of Artemis null cells can also be identified in 
this late arresting category. Size analysis and staining for senescence associated β-gal 
(SAβ-gal ) indicated that these are non-dividing, non-senescent cells (Fig. 5B) distinct 
from the SAβ-gal positive arrested population. 
 Taken together, these findings suggest that after 4 Gy, whereas control cells 
continue cell division and Artemis null cells fail to undergo cell division, a significant 
proportion of F96-224 cells undergo 6-7 divisions before arresting as small, non-
senescent cells. 
 
 
F96-224 cells display elevated levels of dicentric chromosomes post irradiation. 
A significant proportion of F96-224 cells continue to cycle for 6 to 7 divisions post 
irradiation. This suggested that F96-224 cells are able to escape from cell cycle 
checkpoint arrest while maintaining damage that causes delayed cell death. One potential 
model we considered is that F96-224 cells harbour elevated chromosome aberrations. An 
important aberration in this context is a dicentric chromosome, which will lead to 
breakage bridge fusion events at subsequent cell divisions. We, therefore, examined 
chromosome breakage and particularly dicentric formation in F96-224, CJ179 (Artemis 
null), and 1BR3 (control) cells. Our analysis revealed  that F96-224 and CJ179 displayed 
similar levels of total chromosome damage (2.9 and 2.7 breaks per metaphase; p < 0.05)  
which was significantly elevated compared to 1BR3 (1.6 breaks per cell) (Table 1). 
However, F96-224 cells showed a four fold elevated frequency of dicentric chromosomes 
compared to control cells, with 21 % of the metaphase cells displaying dicentric 
chromosomes.  Dicentric formation in F96-224 cells also appeared elevated compared to 
CJ179 cells. However, it is noteworthy that it was difficult to obtain high numbers of 
metaphase chromosomes from the CJ179 irradiated population most likely because the 
cells remained arrested at the G2/M checkpoint due to the significant DSB repair defect, 
making it difficult to assess the significance of the difference in dicentrics observed in 
F96-224 relative to CJ179 cells 
 
Discussion. 
F96-224 is a cell line derived from a patient who displayed progressive combined 
immunodeficiency (9). A sibling of the patient displayed a similar condition.  Previously, 
we demonstrated that the patient’s lymphocytes showed elevated spontaneous apoptosis 
and the fibroblasts displayed elevated radiosensitivity (9). 
Here we show that the patient is an Artemis-deficient compound heterozygote 
with novel Artemis mutations; in one allele the mutation results in a G126D amino acid 
change and in the other allele the mutational change causes loss of a single amino acid 
(L70). Both of these mutations lie within the β-Casp domain, which has been shown to be 
important for function. We demonstrate that expression of cDNAs carrying either 
mutational change fails to complement the DSB repair defect of an Artemis null cell line 
demonstrating that they represent impacting mutational changes. Furthermore, we show 
that there is dramatically reduced, although detectable, Artemis protein in F96-224 cells. 
Together, these findings provide strong evidence that deficiency in Artemis function 
underlies the progressive combined immunodeficiency observed in the patient. 
The majority of Artemis defective patients have genomic deletions causing loss of 
Artemis function (3). Such patients normally display severe combined immunodeficiency 
(T-B- SCID), consistent with an obligatory role for Artemis in hairpin cleavage during 
V(D)J recombination (3). The slightly milder immunodeficiency observed in the patient 
and sibling suggests that one or both of the mutational changes identified in patient F96-
224 are hypomorphic, a notion consistent with the mutational analysis and ability to 
detect residual Artemis protein in F96-224 cells.  This notion is further substantiated by 
our DSB repair analysis, which demonstrates reduced but residual DSB rejoining in F96-
224 cells compared to the defect observed in an Artemis null cell line. Three other 
Artemis null cell lines show a similar persistent DSB repair defect (2). Additionally, in 
our complementation analysis, the 377A>G myc Art cDNA, reproducibly showed a slight 
ability to complement Artemis null cells suggesting that it may represent a hypomorphic 
allele. However, due to insensitivity of this assay, this difference was on the borderline of 
significance. To date, we have been unable to express stable mutant Artemis protein for 
activity analysis.  However, we previously found normal V(D)J recombination in F96-
224 cells following transfection of V(D)J recombination substrate plasmids which is in 
striking contrast to the near complete defect in coding join formation in Artemis null cells 
and provides additional evidence for residual Artemis function in F96-224 cells(9). Taken 
together, our findings provide strong evidence that F96-224 has hypomorphic Artemis 
mutation(s) which significantly reduce, but crucially do not abolish, Artemis function. 
We also demonstrate that γ-H2AX foci analysis is a powerful assay for 
identification of Artemis defects that allows hypomorphic mutants to be identified and 
distinguished from null mutants. The analysis of V(D)J recombination in F96-224 cells, 
in contrast, failed to detect the defect (9). Similarly LIG4 syndrome patients show only a 
subtle defect in the plasmid based V(D)J recombination assay despite displaying a 
pronounced DSB repair defect (10). The insensitivity of the plasmid based V(D)J 
recombination assay is surprising given that F96-224 and LIG4 syndrome patients 
display pronounced immunodeficiency but perhaps reflects the small number of plasmids 
transfected into each cell. 
Although F96-224 cells show an intermediate DSB repair defect compared to 
Artemis null cells, they display a similar level of radiosensitivity. Examination of events 
post-irradiation demonstrated that, while the vast majority of Artemis null cells fail to 
divide even after 2 Gy, the majority of F96-224 cells progress through 5-7 cell divisions 
before finally arresting as small cells. In contrast, control fibroblast populations are able 
to recover from 2 and 4 Gy and proceed through multiple cell divisions. Although a 
previous report suggested that Artemis defective cells have impaired G2/M checkpoint 
arrest, our analysis has demonstrated proficient G2/M checkpoint arrest and, in fact, a 
prolonged arrest compared to control cells, consistent with the characterised repair defect 
(2, 11);Deckbar et al, in preparation).  Our findings, therefore, demonstrate that F96-224 
cells can escape cell cycle arrest, which is not suprising given their ability to rejoin DSBs 
with slow kinetics. However, their delayed cell death suggests that the DSBs might be 
repaired inaccurately. Strikingly, chromosome analysis of irradiated F96-224 cells 
demonstrated that 21 % of the F96-224 metaphase cells formed 8-24 h following 
irradiation with 3 Gy harboured dicentric chromosomes. One potential model to explain 
our findings is that the DSB repair defect in F96-224 cells promotes inaccurate rejoining 
either via residual Artemis activity or via an alternative mechanism, leading to telomeric 
break fusions and/or dicentric formation. Coupled with the residual DSB repair defect, 
cells with such lesions escape from G2/M checkpoint arrest but undergo subsequent 
breakage-bridge fusion events and delayed cell death. Dicentrics were also observed in 
Artemis null cells, suggesting that their formation may be Artemis independent. 
However, it is also possible that the slow DSB rejoining in F96-224 cells promotes 
dicentric formation. The failure of Artemis null cells to display delayed cell death after 
the doses examined is most likely due to the greater number of persistent unrepaired 
DSBs triggering permanent cell cycle arrest. Thus, the residual DSB repair activity in 
F96-224 cells provides only a transient benefit in response to 2 and 4 Gy irradiation. 
Further work is required to carefully monitor chromosome aberrations at differing times 
post irradiation. However, since only a single unrepaired DSB may be sufficient to 
trigger cell cycle arrest, elevated damage may not be readily detectable. It will also be 
interesting to determine whether this novel phenotype is unique to F96-224 cells or is a 
feature common to other hypomorphic repair deficient cell lines. 
It is tempting to speculate that delayed cell death may underlie the unusual 
clinical phenotype of progressive combined immunodeficiency shown by patient F96-224 
and his sibling. At an early age, patient F96-224 had nearly normal lymphocyte counts 
which decreased dramatically during childhood (Fig. 6). Thus, it is possible that DSBs 
induced during V(D)J recombination also generate dicentric chromosomes or other 
abnormal rejoining events which allow cell cycle progression and hence lymphocyte 
development but underlie subsequent or delayed cell death. Such an explanation  might 
also explain the elevated spontaneous apoptosis previously observed in F96-224 
lymphocytes (9). Interestingly, a previous study demonstrated elevated N-myc 
amplification in Artemis null mouse cells which was proposed to result from dicentric 
formation and amplification via breakage bridge fusion events (12). 
  In conclusion, we describe a novel clinical manifestation of impaired but not 
ablated Artemis activity, namely progressive combined immunodeficiency. We describe 
a valuable assay suitable for clinical diagnosis that can detect loss or impaired Artemis 
function and distinguish between the two. Our analysis of the cellular impact of impaired 
Artemis function has shown that it can lead to delayed cell death after DSB formation. 
We provide evidence that this correlates with elevated dicentric formation and escape 
from cell cycle checkpoint arrest due to delayed DSB rejoining and suggest that these 
findings could be explained by a breakage bridge fusion model. We suggest that delayed 
cell death might underlie the progressive immune deficiency displayed by the patient. 
Materials and Methods. 
The patient. 
Case reports of the patient and his sibling have been described previously (9). In brief, 
the patient’s sibling displayed progressive immunodeficiency with lymphopaenia of T 
and B cells. The patient was investigated from the age of 15 months. At 6 months of age 
he had minor infections. As a result of the decreasing lymphocyte counts, he underwent 
bone marrow transplant at age 4 years and died from transplant related complications. 
 
Cell Lines and Cell culture conditions. 
F96-224 is a primary fibroblast cell line established from the patient. CJ179 and F02-98 
are primary fibroblast cell lines established from Artemis null patients described 
previously (2). CJ179 and F02-98 cells have genomic deletions in Artemis and no 
detectable Artemis transcript using primers to either the 3’ or 5’ region of the gene. 
CJ179 hTERT, used for complementation analysis, is a hTERT immortalised derivative 
of CJ179. Control fibroblast lines, 1BR3 and 48BR were also used. Fibroblasts were 
cultured in MEM (Gibco/Invitrogen Ltd, Paisley, UK) supplemented with 15 % FCS, 
0.2% sodium bicarbonate, 2 mM glutamine, 100 U ml-1 penicillin G and 100 µg ml-1 
streptomycin at 37°C, 5% CO2. 
 
Irradiation and Radiosensitivity Assay. 
Fibroblasts were irradiated using a 137Cs γ-ray source at a dose rate of 0.09 Gy sec-1. 
Radiosensitivity was assessed by colony survival assay following 0, 1, 2, 4 and 6 Gy 
irradiation. Dilutions of 200, 400, 800 and 1600 cells were plated and left for 3 weeks 
prior to colony staining (Methylene Blue) and counting. 
 
Artemis Sequencing. 
Total RNA was extracted from F96-224 fibroblasts and cDNA was synthesised using 
random hexamer primers and SUPERSCRIPT II reverse transcriptase (Invitrogen, 
Paisley, UK).  PCR amplification of Artemis cDNA was performed in two separate 
reactions (yielding overlapping products) with Pfx polymerase (Invitrogen). 5’ Artemis 
(1160bp ) was amplified with primers (upper and lower) 5’-
GATCGGCGGCGCTATGAGTT-3’ and 5’-GGTGAACTGTTCTAGCTCTC-3’. 3’ 
Artemis (1177bp) was amplified with primers 5’-CCTCCTACAGTGAGATTAAA-3’ 
and 5’-TGTCATCTCTGTGCAGGTT-3’ (94 °C for 2 min, then 35 cycles of 94°C, 15 
sec; 54 °C for 30 sec; 68 °C for 1 min 30 sec; then 68 °C for 10 min).  Each fragment was 
amplified three times in separate PCR reactions, gel purified, and sequenced in both 
directions using ABI BigDye Terminator Cycle Sequencing Kit V1.1 (Applied 
Biosystems, Foster City, CA). The primers employed in the initial PCR reactions were 
used in combination with the following sense (U) and anti-sense (L) primers to sequence 
amplified Artemis cDNA:  5’ fragment (U2: 5’-AGGAGACTTCAGATTGGCG-3’; U3: 
5’-TGGTTTGGAGAAAGGAGC-3’; L4: 5’-TGCTGATTATGTGGAGTGG-3’; L5: 5’-
TCTTCCTTCTCTCCTGATGC-3’) .  3’ fragment ( U4: 5’-
TGAGACAAACCCCAGGATG-3’; U5: 5’-CCCGAGGAAAAAAGTTTGC-3’; L2: 5’-
GGAGTAAGTATCCTTTGGGC-3’; L3: 5’-TCTCAGTTTTTCAGGCTGC-3’). 
 
Western blotting. 
For analysis of Artemis by Western blotting, 50 µg of cell extracts were resolved on a 
7.5% PAGE gel. Following transfer to nitrocellulose and electroblotting, blocking with 
25 % skim milk powder in TTBS buffer (20 mM TrisBase –HCl pH 7.5; 150 mM NaCl; 
0.1 % Tween-20 ), the blots were incubated overnight at 4oC with anti-Artemis antibody 
(Orbigen, San Diego; Insight Biotechnologies,  London) at 1:2000 dilution. Following 
washing, the blots were incubated with secondary antibody (Anti-Rabbit HRP) 
(Dakocytomation Ltd, Cambridgeshire, UK) at 1:2000 dilution. Amersham ECL reagent 
(Biosciences, Buckinghamshire, UK) was used for detection.       
 
DSB repair analysis and complementation. 
γ-H2AX foci analysis was performed using non-dividing, confluent cultures (at least 98 
% of the cells in G1). This is important to ensure that the foci analysed represent DSBs. 
Following irradiation at the indicated dose, cells were processed for immunofluorescence 
using anti-pH2AX antibodies as described previoulsy(13, 14). For complementation 
analysis, CJ179 hTERT cells were transfected with wild type or mutant Artemis cDNA 
cloned into pCI-neo-c-Myc using the AMAXA transfection protocol for adherent cell 
lines (Solution R, program A-24) (Amaxa Biosystems, Koeln Germany) . 24 h post 
transfections, cells were exposed to 10 Gy γ-rays and analysed for 53BP1 foci 16 and 24 
h later. Foci were scored into the Myc positive cells representing those that have been 
successfully transfected. Approximately 10 - 20 % transfection efficiency was obtained. 
a-myc antibody (BL181) was from Bethyl, California, US). Mutations in Artemis were 
introduced using Quickchange XL site-directed mutagenesis kit (Stragene, La Jolla, CA). 
 
Analysis of post irradiation cell division using CFSE 
Carboxy-fluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Leiden, 
Netherlands) was dissolved in dimethylsulphoxide (DMSO) at a concentration of 5 mM 
as a stock solution and stored in aliquots at -20°C.  Fibroblasts were seeded at a density 
of 5 x 104 in 10 cm tissue culture plates and incubated overnight to allow them to adhere. 
Duplicate plates were prepared for each dose and time point.  Cells were washed once 
with 5 ml Opti-MEM (Invitrogen, Paisley, UK), CFSE stock was diluted 1/1000 in Opti-
MEM (5 µM final concentration) and 5 ml of this was added to label each cell culture.  
Cells were incubated with CFSE for 10 min at 37°C, 5 % CO2, washed twice with 5 ml 
Opti-MEM, followed by the addition of fibroblast culture medium.  Cells were then 
irradiated and incubated at 37°C, 5 % CO2.  FACS analysis was then performed counting 
15,000 events per sample. 
 
Two protocols were followed. For early post-IR division experiments, CFSE labelled 
cells were treated with 0, 1, 2, or 4Gy γ-radiation on day 0. Control cells were trypsinised 
immediately after labelling on day 0, fixed in 1 % paraformaldehyde (PFA) and stored at 
4 °C. FACS analysis for cell size and CFSE intensity was performed afterincubation for 6 
days (37°C, 5 % CO2). For late division experiments, cells were treated with 0, 1, 2, 4 or 
6 Gy γ-radiation on day zero and incubated for 5 days at 37 °C, 5 % CO2.  CFSE labelling 
was then performed as described above and cultures were incubated for a further five 
days at 37 °C, 5 % CO2 before analysis on day 10.  During this period any unirradiated or 
low dose cultures that approached confluence were split either 1:4 or 1:8 to maintain 
exponential growth conditions.  
 Analysis of post-irradiation cell subpopulations.  
Cells were labelled with CFSE and irradiated with 4 Gy and processed as for the late 
division experiments previously described.  The 0 day labelling control was used to set 
the highest level of CFSE fluorescence, and the mock irradiated sample represented cells 
that had divided normally in this time frame.  Irradiated cells were sorted into high, 
medium and low CFSE fluorescence populations according to the gates shown in figure 5 
using a Coulter EPICS ALTRA cell sorter.  Approximately 5 x 104 – 1.5 x 105 cells were 
sorted for each population.  Cells were then plated, and cell morphology and senescence 
associated β-galactosidase (SA-βgal) activity was examined.  Photographs were taken 
using a Nikon-F70 camera in conjunction with a Nikon TMS-F microscope at 100x 
magnification. 
 
Senescence Associated β-Galactosidase (SA-βgal) staining of CFSE labeled cells. 
Fibroblasts were washed once with PBS and fixed in tissue cultures plates with 3 % 
formaldehyde.  Fixed cells were then washed 3 times with PBS and incubated at 37 °C 
overnight with SA-βgal staining solution (40 mM Citric Acid, 12 mM Sodium Phosphate, 
5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 150 mM NaCl, 2 mM MgCl2, 1mg ml-1 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-gal)).  
 
Chromosome analysis. 
Exponentially growing cells were irradiated or mock irradiated with 3 Gy using a 137Cs γ 
source at a dose rate of 0.09 Gy sec-1.  After incubation (8 h, 37°C), 150 µl of Colcemid 
solution (10 µg ml-1, Invitrogen, Paisley, UK) were added and flasks incubated overnight.  
Cells arrested at metaphase were harvested by partial trypsinisation for 2 min at room 
temperature.  Cells were resuspended in 5 ml preheated (37 °C) 1 % sodium citrate , 
incubated (37 °C, 15 min), centrifuged  (1200 rpm, 5 min) and resuspended in 10 ml of 
fix solution (3 : 1, methanol : acetic acid). Fixed cells were washed 3 times in 5 ml of fix 
solution, resuspended in 1 ml of fix solution and dropped onto clean glass slides using a 
Pasteur pipette.  After drying, cells were stained with Giemsa  (10 min). Metaphase 
spreads were visualised by light microscopy at 1000x magnification using a Zeiss 
Axioskop microscope (Photometrics, Tucson, USA) and the number of unrepaired 
chromosome and chromatid breaks were counted per metaphase.  Chromosome breaks 
were defined as acentric chromosome fragments and chromatid breaks were defined as 
chromatid gaps (larger than a chromatid width) or fragments.  We also noted the number 
of dicentric chromosomes observed.   
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Figure Legends. 
 
Figure 1. F96-224 is a hypomorphic Artemis deficient cell line. 
a) F96-224 cells show impaired but residual DSB rejoining after irradiation. 
γ-H2AX foci were counted at the indicated times following exposure to 3 Gy γ-rays. h 
represents hours and D, days. 48BR is a control cell line, 180BR is a DNA ligase IV 
deficient cell line and F02/385, an Artemis null cell line.  180BR cells show impaired 
rejoining of all DSBs; F02/385 cells show a fraction (approximately 10 %) of unrepaired 
DSBs that persist for long periods (up to 8 days shown); F96-224 cells show slow 
rejoining of the Artemis-dependent fraction of DSBs. The results represent the mean and 
standard deviation of 3 experiments. 
b) F96-224 cells have reduced but detectable Artemis protein. 
Whilst no residual protein was detectable in Artemis null, F02/385 cells, F96-224 cells 
show low residual protein. Western blotting was carried out using α-Artemis antibodies. 
c) ∆GTT207-9 and 377G>A are impacting Artemis mutations. 
cDNAs expressing wild type myc tagged Artemis cDNA (CJhTERT + myc-ART), 
∆GTT207-9 myc-Art cDNA (CJhTERT + ∆GΤΤ) or 377G>A myc-Art cDNA (CJhTERT 
+ G377A) were transfected into Artemis null, CJ179 hTERT cells. 24 h later, cells were 
exposed to 10 Gy γ-rays and the number of 53BP1 foci scored 16 and 24 h later in those 
cells expressing Myc. As controls, cells were either untransfected (CJhTERT - DNA) or 
transfected with gfp expressing vector (CJhTERT+gfp). Control cells, (48BRhTERT) 
were also examined either without transfection or following transfections with gfp vector 
DNA. When gfp expressing vectors were used, g-H2AX foci were scored in gfp 
expressing cells rather than Myc expressing cells. Whereas wild type myc-Art cDNA 
substantially corrects the DSB repair defect in CJ179 hTERT cells, no substantial 
correction was observed with either mutant cDNA demonstrating that the two mutational 
changes impact upon Artemis function. The results represent the mean and standard 
deviation of 3 experiments. 
 
Figure 2. Radiosensitivity of Artemis fibroblast lines. 
F96-224 cells shows a similar level of radiosensitivity to an Artemis null cell line, CJ179. 
Results show colony survival 3 weeks following irradiation and represent the mean and 
standard deviation of at least 3 independent experiments. 
 
Figure 3. CFSE assay for post-irradiation cell division. 
a) Analysis of cell division by monitoring CFSE levels using FACS. 
1BR3 cells, labelled by 10 min growth in the presence of CFSE, were analysed by FACS 
0 and 6 days either without or following irradiation (4 Gy). Cells were sorted using the 
intensity of fluorescence (CFSE) signal. Following each division, the level of CFSE/cell 
decreases. In unirradiated cells, the position of the peak significantly shifts to the left 
consistent with the cells having undergone approximately 6 cell divisions. After 4 Gy, the 
majority of irradiated cells are permanently arrested after 1 - 2 divisions although a 
significant percentage resume cycling (highlighted as dividing) and have progressed 
through approximately 5 divisions by 6 days.  
b) Examination of cell cycle state by Forward and Side Scatter FACS analysis. 
Cycling, unirradiated 1BR3 cells (0 Gy) show low Forward and Side Scatter (FS and SS) 
by FACS, indicating the prevalence of a small, predominantly G1 cell population. Cells 
irradiated with 4 Gy show a significant shift towards high forward and side scatter, 
indicating larger, more granular cells, typical of arrested fibroblasts. The lower panel 
shows CFSE profiles of cells with either high (right box in the upper panel) (shaded 
profile) or low (left box in upper panel) (open profile) FS and SS representing large and 
small cell populations, respectively. The results demonstrate that the high CFSE 
population (ie cells that have not divided) is composed predominantly of large arrested 
cells. 
 
Figure 4 F96-224 cells show early post IR division 
Cells (1BR3, CJ179 or F96-224) were labeled by 10 min growth in CFSE, then irradiated 
(0, 1, 2, 4 Gy), and incubated for 6 days before FACS analysis. a) Figure showing the 
percentage of cells that have completed 5 dividions b) FACS profiles showing CFSE 
staining of cells gated as high or low FS and SS. Shaded profile represents the high FS 
and SS population (ie large cells; right box in Fig 3B); Open profile represents low FS 
and SS population (ie smaller cells; left box in Fig 3B). F96-224 show a higher 
percentage of small dividing cells compared with CJ179 after 2 and 4 Gy, and in fact 
have a profile similar to that of 1BR3 cells. 
 
 
Figure 5 F96-224 cells arrest after 6-7 divisions as small, non-senescent cells. 
Cells (1BR3, CJ179 or F96-224) were irradiated (4 Gy) and incubated for 5 days before 
addition of CFSE. The cells were then incubated for a further 5 days before analysis of 
CFSE content by FACS, gating on cells with high or low FS and SS as in Figs 3 and 4. 3 
populations of CFSE stained cells are apparent: cells which have passed through 5 further 
divisions (lowest CFSE); cells which have not divided at all (population 1, highest CFSE, 
large cells), and, in F96-224 and CJ179, an intermediate population (2) of small cells 
which have divided an additional 1-2 times. This time the F96-224 population looks 
distinct to 1BR3 cells and few cells have undergone more than 2 divisons. b) Populations 
1 and 2 were sorted by FACS, plated and examined following staining with SA-β-gal .  
 
Figure 6. Patient F96-224 displayed progressively decreasing lymphocyte numbers. 
Lymphocyte numbers in patient F96-224 were monitored from 8 months of age.  Whilst 
lymphocyte numbers where within the control range 8-10 months after birth, the numbers 
decreased after 24 months of age. 
 
  
